Incidence of Adverse Events Days 0 - 84 [clinicaltrials_resource:5e3b62b179de78c1263a907f80d4045b]
Number of participants experiencing adverse events (includes both adverse events and serious adverse events)
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Incidence of Adverse Events Days 0 - 84 [clinicaltrials_resource:5e3b62b179de78c1263a907f80d4045b]
Number of participants experiencing adverse events (includes both adverse events and serious adverse events)
Bio2RDF identifier
5e3b62b179de78c1263a907f80d4045b
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:5e3b62b179de78c1263a907f80d4045b
measure [clinicaltrials_vocabulary:measure]
Incidence of Adverse Events
time frame [clinicaltrials_vocabulary:time-frame]
Days 0 - 84
description
Number of participants experie ...... ts and serious adverse events)
identifier
clinicaltrials_resource:5e3b62b179de78c1263a907f80d4045b
title
Incidence of Adverse Events Days 0 - 84
@en
type
label
Incidence of Adverse Events Da ...... b62b179de78c1263a907f80d4045b]
@en